Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.
about
Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinomaHigh Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.Evaluation of Nasal and Nasopharyngeal Swab Collection for the Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma.Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.The Role of Epstein-Barr Virus DNA Load and Serology as Screening Tools for Nasopharyngeal Carcinoma.Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer.EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma.
P2860
Q33743639-637D58BB-69B5-43E0-89B5-8306F9003466Q36424931-3BDFDB95-1E88-4549-AB21-A7BEA450CF66Q37100066-0467C00D-0C2D-4827-9918-E40F85DE096EQ38612223-42325747-927E-4175-A71B-E00C0BFA54EDQ38735125-07DA696F-FEA0-4172-BFED-36D2147775D1Q39172624-542C7993-FF13-40D0-B1E1-5B0107828873Q40085909-EF7096D9-E738-4BFD-9ED3-258EC9B57008Q40770021-A79BE20B-108F-4930-AFCB-D66EC788AE52Q47551595-6DAC99FD-0DEE-42EC-82D0-0E304913DB5DQ52593708-152B4A8A-789F-48AC-B588-A3FF5805E625Q52685801-4BAE751F-E138-4E5C-A53D-1CC198AFA795
P2860
Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@ast
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@en
type
label
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@ast
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@en
prefLabel
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@ast
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@en
P2093
P2860
P50
P1476
Epstein-Barr virus serology as ...... multiplex families in Taiwan.
@en
P2093
Allan Hildesheim
Anna E Coghill
Chien-Jen Chen
Hedy Juwana
Jen-Yang Chen
Kelly J Yu
Ruth M Pfeiffer
Wan-Lun Hsu
P2860
P304
P356
10.1158/1055-9965.EPI-13-1262
P577
2014-04-27T00:00:00Z